MB

MPM BioImpact Portfolio holdings

AUM $577M
1-Year Est. Return 8.33%
This Quarter Est. Return
1 Year Est. Return
+8.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$577M
AUM Growth
-$4.53M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$13.8M
2
+$13.8M
3
+$10.5M
4
DBVT
DBV Technologies
DBVT
+$9.65M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$8.07M

Top Sells

1
+$22.7M
2
+$18.2M
3
+$10.4M
4
TWST icon
Twist Bioscience
TWST
+$10.3M
5
NTRA icon
Natera
NTRA
+$9.82M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEM icon
1
Cullinan Oncology
CGEM
$543M
$57.6M 9.98%
7,648,268
MDGL icon
2
Madrigal Pharmaceuticals
MDGL
$9.78B
$30.4M 5.27%
100,415
ZLAB icon
3
Zai Lab
ZLAB
$3.28B
$26.1M 4.51%
745,060
-88,599
GH icon
4
Guardant Health
GH
$8.4B
$23M 3.99%
442,656
SPRY icon
5
ARS Pharmaceuticals
SPRY
$1.09B
$22.7M 3.94%
1,303,399
-9,705
EWTX icon
6
Edgewise Therapeutics
EWTX
$1.67B
$22.6M 3.91%
1,720,741
+615,297
RNA icon
7
Avidity Biosciences
RNA
$7.44B
$21.6M 3.74%
760,022
+45,798
PTCT icon
8
PTC Therapeutics
PTCT
$5.41B
$21.4M 3.71%
438,477
-1,500
TRVI icon
9
Trevi Therapeutics
TRVI
$1.35B
$18.6M 3.23%
3,406,955
-21,411
ORIC icon
10
Oric Pharmaceuticals
ORIC
$1.36B
$17.6M 3.04%
1,729,378
+329,864
NTRA icon
11
Natera
NTRA
$25.5B
$16.7M 2.9%
98,924
-58,123
ALKS icon
12
Alkermes
ALKS
$5.28B
$15.7M 2.72%
549,262
+211,659
MLTX icon
13
MoonLake Immunotherapeutics
MLTX
$631M
$14.8M 2.56%
313,571
-2,478
MBX
14
MBX Biosciences
MBX
$642M
$14.8M 2.56%
1,294,416
+161,466
CMPX icon
15
Compass Therapeutics
CMPX
$812M
$14.6M 2.53%
5,622,505
-2,820,278
RARE icon
16
Ultragenyx Pharmaceutical
RARE
$3.27B
$14.4M 2.49%
395,700
-2,745
JANX icon
17
Janux Therapeutics
JANX
$1.72B
$14.2M 2.46%
614,282
+47,089
TARS icon
18
Tarsus Pharmaceuticals
TARS
$3.23B
$13.8M 2.4%
+341,496
DYN icon
19
Dyne Therapeutics
DYN
$2.4B
$13.8M 2.39%
+1,446,361
VERA icon
20
Vera Therapeutics
VERA
$2B
$13.3M 2.3%
563,075
+147,356
CRNX icon
21
Crinetics Pharmaceuticals
CRNX
$4.18B
$12.3M 2.14%
428,975
-202,989
RVMD icon
22
Revolution Medicines
RVMD
$9.59B
$11.6M 2.01%
315,722
-1,361
AKBA icon
23
Akebia Therapeutics
AKBA
$806M
$10.5M 1.82%
+2,889,125
OLMA icon
24
Olema Pharmaceuticals
OLMA
$717M
$10.1M 1.76%
2,378,762
-551,684
XENE icon
25
Xenon Pharmaceuticals
XENE
$3.26B
$10.1M 1.75%
323,398
+20,000
1
2 3